Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

    Supports centers that optimize late-stage biomedical technologies and sustainably disseminate them to the wider research community in areas within the NIGMS mission; clinical trials are not allowed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

    Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.

    HHS-NIH11Due Feb 5, 2027

    NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

    NIH supports development of next-generation diagnostic and therapeutic devices aligned with its brain research and addiction initiatives, preparing them for first-in-human trials; clinical trials are not allowed.

    HHS-NIH11Due Feb 1, 2027$2,250,000

    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

    NIH supports national biomedical imaging and bioengineering centers that develop research-driven technologies, share them with investigators, and train researchers in their use.

    HHS-NIH11Forecasted Jan 25, 2027Forecasted

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    HHS-NIH11Due Feb 5, 2027$1,000,000

    Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

    NIH supports small, multidisciplinary teams using bioengineering to solve biomedical problems and advance tools, with optional trials to test functionality or performance, excluding phase III trials.

    HHS-NIH11Due Feb 5, 2027$2,500,000